Navigation Links
Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
Date:12/26/2007

SEATTLE, Dec. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) management to hold a conference call tomorrow (Thursday, December 27) at 8:30 am EST to discuss update on Zevalin asset purchase, CMS reimbursement, and PIX301 timing for results.

Conference Call Numbers

Thursday, December 27

8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific

800-218-0204

303-262-2130

Webcast available at

http://www.cticseattle.com -

webcast will be archived approximately two hours after call ends.

Call-back numbers for post listening available at 10:00 am Eastern

800-405-2236

303-590-3000

Passcode: 11105647

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Susan Callahan

T: 206.272.4472

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... PARIS, November 27 S...market Oralair(R) in both adults and children,thro...irst country where,Oralair(R) has been marketed, w...R) is now registered in Austria, Belgium, Bulgaria...many, Greece, Hungary, Ireland, Italy,Latvia, Lit...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech firm..., genomic data from the 1918 pandemic through the ...H1N1 pandemic, today issued its latest biochemical...e lethality of the H1N1 ("Swine Flu") virus has dr...irus,s current outbreak in the spring of 2009 to r...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/ -- S...d provider of vaccines, announced today that it ex... Sinovac (Dalian) Vaccine,Technology Co., Ltd. (Si...uce,and commercialize human-use vaccines. Sinovac ...veloping and commercializing world-class vaccines;...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES...electrical and communications systems and services...rkets, announced today that its commercial busines... Torcon JV to install the electrical systems for t...lity at the U.S. Army Medical Research Institute o...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...uticals, Inc.,a privately-held specialty pharmaceu...d ceftazidime for injection, USP, a semisynthetic,...l offer ceftazidime in 1,and 2g single dose vials ...MS data, 2007 sales of injectable amiodarone in th... "Sagent is proud to be providing tools to the he...
...nces, Inc. (Nasdaq: HGSI ) today announced that D...ard of Directors. He will also serve as a,member o...r. Southwell was,at Sepracor, Inc., a research-bas...utive Vice President and Chief Financial Officer, ..., Development and Licensing., (Logo: http://www....
...nificantly change virtually every facet of the way...to shape these changes and to ensure that nanotech...identified and controlled. A new report by former ... clear roadmap for the next presidential administr...steps necessary to deal with the current shortcomi...
Other Biology Technology:Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 4Nanotech: A regulatory blueprint for the next administration 2
(Date:11/24/2009)...stallised a protein that may help gut bacteria bin... be used by probiotic producers to identify strain... , "Probiotics need to interact with cells lining...attach to surfaces in the gut they are more likely...ty," says Dr Nathalie Juge from the Institute of F...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...he community-associated strain of the deadly super... most common antibioticsposes a far greater health...y into hospitals, according to a study in the Dece... The new threat is easily picked up in fitness cen...reased the overall burden of MRSA within hospitals...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Bringing harmony to electronic waste disposal 56281 1Bringing harmony to electronic waste disposal 56281 2To get college students to wash hands requires proper tools attention getting tactics 56279 1To get college students to wash hands requires proper tools attention getting tactics 56279 2The first DNA barcodes of commonly traded bushmeat are published 9800 1The first DNA barcodes of commonly traded bushmeat are published 9800 2The first DNA barcodes of commonly traded bushmeat are published 9800 3
...Chicago study has been stopped early due to prelim... of men reduces their risk of acquiring HIV during...dy,s independent Data Safety and Monitoring Board ...he board,s review, the National Institutes of Heal...nrolled in the study who remain uncircumcised be o...
... pupfish is a small place. The entire species live...rs wide, in a cave entrance in Death Valley, Calif...so has a profound effect on the fishes, appearance...protected from extinction. , In 1976, the inch-lon...ached the U.S. Supreme Court. Conservationists had...
...University School of Medicine suggests that certai...hemicals our bodies produce during times of high s...ailure and lupus that involve inflammation. , The ...tthew Loza, Ph.D, found that beta-agonists, such a...the accumulation of type 2 T cells, a type of whit...
Other Biology News:Male circumcision reduces HIV risk, study stopped early 2Male circumcision reduces HIV risk, study stopped early 3Research suggests beta agonists may alter the immune system 2
Agarose-ME from GE Healthcare, formerly Amersham Biosciences
luciferase Assay Kit from BioVision
Sheep Serum from CHEMICON
...Alkaline Phosphatase, Calf Intestinal (CIAP), cata...A, RNA, and ribo- and deoxyribonucleoside triphosp...ation and religation of linearized cloning vector ...ni and may also be used for the dephosphorylation ...
Biology Products: